Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Excessive Sleepiness in OSAHS with Comorbid Depression
NCT00518986Phase 4Completed
- Sponsor
- Cephalon, Inc.
- Start
- Oct 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of armodafinil in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Cephalon, Inc.. Started Oct 2007; status: completed.
02
Drugs
armodafinil
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on NCT00518986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518986.